La Posada Pintada

Bluff,
UT
(2015)

La Posada Pintada

Business Development, Rural

NMTC financing for the expansion of La Posada Pintada, a family-owned inn in Bluff, where traditional sources of financing have been hard to obtain for small-business owners in the rural community.

Investment

NMTC Amount: $565,000
Total Project Cost: $618,770

IMPACT

2 FTE jobs
1 construction jobs

CDEs

Stonehenge Community Development

Investor

Unknown

Project Description

Financing for the expansion of La Posada Pintada, a family-owned inn in Bluff, where traditional sources of financing have been hard to obtain for small-business owners in the rural community.

The expansion from six rooms to 10 at La Posada Pintada created jobs and to increased occupancy rates and consumer spending in the area, which is popular with tourists traveling to the Grand Canyon, Moab, Mesa Verde and Monument Valley.

MAP

Address: 239 North Seventh E, Bluff, UT 84512

Census Tract: 49037978200

Other Utah Projects

Utah Community Action Head Start

South Salt Lake,
UT
(2014)

Community, Daycare and Early Childhood, Youth and Families

CDE(s): Community Development Finance Alliance

Salt Lake Community Action Program's 13,080 sq. ft. Head Start facility, serving 150 preschool age children living in poverty annually.

Bicycle Collective Hub, Inc.

Salt Lake City,
UT
(2023)

Recreation

CDE(s): Mofi

The project involves the construction of a new 16,090 sq. ft. facility in Salt Lake City, Utah. The project will allow the Bicycle Collaborative, a nonprofit providing bicycles and educational

Utah Community Action Kearns Head Start

Kearns,
UT
(2018)

Community, Daycare and Early Childhood, Dental Services, Healthcare, Youth and Families

CDE(s): Community Development Finance Alliance

New construction of a multi-use building that provides four Head Start classrooms, two Early Head Start classrooms, three medical exam roos, one dental exam room, and more.

Recursion Pharmaceuticals

Salt Lake City,
UT
(2021)

Business Development, Manufacturing

CDE(s): Advantage Capital

Working capital for recursion Pharmaceuticals, which provides data driven drug discovery aiming to repurpose existing drugs to cure rare genetic diseases.